0.4049USD+0.72%Mkt Cap: 16.20M USDP/E: —Last update: 2026-05-26
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The …
Industry Peers
Pharmaceutical RetailersIndicators:|
Key Statistics
Company
Market Cap16.20M USD
Enterprise Value12.72M USD
Revenue (TTM)477.68K USD
Gross Profit331.48K USD
Net Income (TTM)-41.51M USD
Revenue/Share0.0210 USD
Last Price0.4049 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryPharmaceutical Retailers
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.90
PEG—
EV/EBITDA-0.83
EV/Revenue26.63
P/S34.02
P/B0.23
EPS (TTM)-2.45
EPS (Forward)-0.21
52W Range
0.23807% of range2.600
52W High2.600 USD
52W Low0.2380 USD
Profitability
Gross Margin76.80%
Oper. Margin-6230.80%
EBITDA Margin0.00%
Profit Margin-9618.03%
ROE-59.20%
ROA-49.31%
Growth
Revenue Growth449.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.38M USD
CapEx (TTM)—
FCF Margin34.04%
FCF Yield1.00%
Net Debt-3.53M USD
Net Debt/EBITDA0.23
Balance Sheet
Debt/Equity0.00
Current Ratio1.70
Quick Ratio1.52
Book Value/Sh1.726 USD
Cash/Share0.0870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 19, 2024
Pay DateJul 24, 2024
Splits
Last Split1:15
Split DateJun 22, 2023
Analyst Consensus
Rating—
Target (Mean)1.500 USD
Target Range1.500 USD – 1.500 USD
# Analysts1
Ownership
Shares Out.40.63M
Float32.79M
Insiders13.31%
Institutions3.87%
Short Interest
Short Ratio1.9d
Short % Float3.83%
Short % Out.3.57%
Shares Short1.45M
Short (prev mo.)2.22M
Technical
SMA 500.3968 (+2.0%)
SMA 2000.6574 (-38.4%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)427.68K
Avg Vol (10d)293.01K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—